Breast intracystic papillary carcinoma: An update

Breast Journal

Volumn 15, Issue 6, 2009, Pages 639-644

  Calderaro, Julien ^a,d   Espie, Marc ^a   Duelos, Juliette ^b   Giachetti, Sylvie ^b   Wehrer, Delphine ^b   Sandid, Wissam ^c   Cahen Doidy, Laurence ^a   Albiter, Marcella ^a   Janin, Anne ^b,c   De Roquancourt, Anne ^b,c  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d Ser Vice d'Anatomle Pathologique   (France)

Author keywords

Breast invasive carcinoma; Breast papillary carcinoma; Breast papillary carcinoma in situ; Intracystic papillary carcinoma

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PARAFFIN; PROGESTERONE RECEPTOR; PROTEIN P63; SMOOTH MUSCLE ACTIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; EMBEDDING; FEMALE; GENE OVEREXPRESSION; HUMAN; INTRACYSTIC PAPILLARY CARCINOMA; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MALE; MYOEPITHELIUM CELL; PAPILLARY CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTOR, ERBB-2;

EID: 70449637918     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00823.x     Document Type: Article

References (36)

1. Kraus FT, Neubecker RD. The differential diagnosis of papillary tumors of the breast. Cancer 1962;15:444-455
2. Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer 1983;52:14-19
3. Hill CB, Yeh IT. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol 2005;123:36-44.
4. Tse GM, Tan PH, Lui PC, et al. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast. J Clin Pathol 2007;60:315-320
5. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19;403-410.
6. Histopathology. 2002;41:151.
7. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligandbinding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-1481
8. 7. Zafrani B, Aubriot MH, Mouret E, et al. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases. Histopathology 2000; 37:536-545 (Pubitemid 32099165)
9. 8. Ross JS, Symmans WF, Pusztai L, Hortobagyi GN. Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes. Clin Cancer Res 2007;13:2831-2835 (Pubitemid 46849556)
10. 9. Goldhirsch A, Click JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16:1569-1583 (Pubitemid 41511089)
11. Allred DC. Problems and solutions in the evaluation of hormone receptors in breast cancer. J Clin Oncol 2008;26:2433-2435
12. 11. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 2007; 131:18-43. (Pubitemid 46174133)
13. 12. Leal C, Costa I, Fonseca D, Lopes P, Bento MJ, Lopes C. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study. Hum Pathol 1998; 29:1097-1104 (Pubitemid 28467530)
14. Knelson MH, el Yousef SJ, Goldberg RE, Ballance W. Intracystic papillary carcinoma of the breast: mammographie, sonographic, and MR appearance with pathologic correlation. J Comput Assist Tomogr 1987;11:1074-1076
15. Tavassoli FA, Devilee P. Pathology and Genetics Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press-WHO, 2003.
16. 15. Lefkowitz M, Lefkowitz W, Wargotz ES. Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases. Hum Pathol 1994;25:802-809 (Pubitemid 24249239)
17. 16. Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 2006;30:1002-1007 (Pubitemid 44264950)
18. 17. Zhang C, Zhang P, Hao J, Quddus MR, Steinhoff MM, Sung CJ. High nuclear grade, frequent mitotic activity, cyclin Dl and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma. Breast J 2005;11: 2-8. (Pubitemid 40209337)
19. Leal CB, Schmitt FC, Bento MJ, Maia NC, Lopes CS. Ductal Carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein. Cancer 1995;75:2123-2131
20. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003;21:28-34.
21. 20. Lam WW, Tang AP, Tse G, Chu WC. Radiology-Pathology conference: papillary carcinoma of the breast. Clin Imaging 2005; 29:396-400. (Pubitemid 41597076)
22. 21. Haji BE, Das DK, Al-Ayadhy B, et al. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary. Diagn Cytopathol 2007;35:40816. (Pubitemid 47021012)
23. 22. Jayaram. G, Elsayed EM, Yaccob RB. Papillary breast lesions diagnosed on cytology. Profile of 65 cases. Acta Cytol 2007; 51:3-8. (Pubitemid 46174091)
24. Tse GM, Ma TK, Lui PC, et al. Fine needle aspiration cytology of papillary lesions of the breast: how accurate is the diagnosis? J. Clin Pathol 2008;61:945-949
25. 24. Carder PJ, Garvican J, Haigh I, Liston JC. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast. Histopathology 2005;46:320-327 (Pubitemid 40343179)
26. 25. Ivan D, Selinko V, Sahin AA, Sneige N, Middleton LP. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy. Mod Pathol 2004;17:165-171 (Pubitemid 41656512)
27. 26. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology 2008; 52:20-29 (Pubitemid 350265188)
28. Shin HJ, Kim HH, Kim SM, et al. Papillary lesions of the breast diagnosed at percutaneous sonographically guided biopsy: comparison of sonographic features and biopsy methods. AJR Am J Roentgenol 2008;190:630-636
29. 28. Mercado CL, Hamele-Bena D, Oken SM, Singer CI, Cangiarella J. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 2006;238:801-808 (Pubitemid 43289910)
30. 29. Ashkenazi I, Ferrer K, Sekosan M, et al. Papillary lesions of the breast discovered on percutaneous large core and vacuumassisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions. Am J Surg 2007;194:183-188 (Pubitemid 47001890)
31. Mulligan AM, O'Malley FP. Papillary lesions of the breast: a review. Adv Anat Pathol 2007;14:108-119
32. 31. Solorzano CC, Middleton LP, Hunt KK, et al. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 2002;184:364-368 (Pubitemid 35287362)
33. 32. Harris KP, Faliakou EC, Exon DJ, Nasiri N, Sacks NP, Gui GP. Treatment and outcome of intracystic papillary carcinoma of the breast. Br J Surg 1999;86:1274. (Pubitemid 29481533)
34. 33. Fayanju OM, Ritter J, Gillanders WE, et al. Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. Am J Surg 2007;194:497-500. (Pubitemid 47370995)
35. Mulligan AM, O'Malley FP. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int J Surg Pathol 2007;15:143-147
36. 35. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720 (Pubitemid 46291835)